Displaying items by tag: department of pathology

The human preclinical model at UAB provides important knowledge before a Phase I clinical trial can begin for living human recipients. Decades of work by researchers across the world preceded UAB’s first clinical-grade pig kidney xenotransplant.

UAB O’Neal Comprehensive Cancer Center, Morehouse School of Medicine and Tuskegee University collectively receive $18 million U54 grant from the National Cancer Institute.

After years of researching the SON gene, Erin Eun-Young Ahn, Ph.D., may have found the cause behind an extremely rare disease. 

The O’Neal Invests program funds UAB investigators starting new cancer-related projects to initiate key, preliminary work needed to enable competitive R01 applications from the NIH.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under

Yabing Chen, Ph.D., is the first researcher at the Birmingham VA to receive this highest honor for a non-physician scientist.

In this arteriolar niche, breast cancer stem cells and arteriolar endothelial cells cross-talk using a well-known signaling pathway. Targeting this pathway may offer therapeutic potential.

Sixto Leal, M.D., Ph.D., was featured in the “Front(line) and Center” category in the Pathologist's 2021 Power List recognizing some of the most inspirational pathologists and laboratory medicine professionals in the U.S. in 2021.

UAB students in the Honors College are equipping the next generation of scientists with cancer biology knowledge through hands-on experiments and interactive projects, helping to spread cancer awareness in Birmingham and surrounding communities.
Elizabeth Brown, Ph.D., has received a $3.1 million grant from the National Cancer Institute to study epigenetic contribution to the excess risk of a precursor of multiple myeloma in African Americans.
Blood shortages are common in the summer months, and COVID-19 has played havoc with usual donation patterns.
Page 1 of 8